SNHG1 and prostate cancer: DNA synthesis in prostate cancer, but not benign, cells virtually ceases in the absence of SNHG1. SNHG1-deficient cells resist G2 arrest when exposed to docetaxel, and the data suggest a decrease in apoptosis, indicating SNHG1 levels influence docetaxel resistance.